These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 2231315)
1. The mode of action of ochratoxin A in acute enteritis in rats. Kanisawa M; Suzuki S; Moroi K J Environ Pathol Toxicol Oncol; 1990; 10(1-2):56-63. PubMed ID: 2231315 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of ochratoxin A in rats. Suzuki S; Satoh T; Yamazaki M Jpn J Pharmacol; 1977 Oct; 27(5):735-44. PubMed ID: 592561 [TBL] [Abstract][Full Text] [Related]
3. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016 [TBL] [Abstract][Full Text] [Related]
4. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797 [TBL] [Abstract][Full Text] [Related]
5. Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats. Kullmann F; Gross V; Rüschoff J; Arndt H; Benda W; Winkler von Mohrenfels A; Schölmerich J Z Gastroenterol; 1997 Mar; 35(3):171-8. PubMed ID: 9106980 [TBL] [Abstract][Full Text] [Related]
6. Histopathological studies on the toxicity of ochratoxin A in rats. I. Acute oral toxicity. Kanisawa M; Suzuki S; Kozuka Y; Yamazaki M Toxicol Appl Pharmacol; 1977 Oct; 42(1):55-64. PubMed ID: 929607 [No Abstract] [Full Text] [Related]
7. Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation. Greenwood-Van Meerveld B; Venkova K; Keith JC J Pharmacol Exp Ther; 2001 Oct; 299(1):58-66. PubMed ID: 11561063 [TBL] [Abstract][Full Text] [Related]
8. Development of multiple necrotizing enteritis induced by a tumor necrosis factor-like cytokine from lipopolysaccharide-stimulated peritoneal macrophages in rats. Torimoto K; Sato N; Okubo M; Yagihashi A; Wada Y; Hara I; Hayasaka H; Kikuchi K Am J Pathol; 1990 Nov; 137(5):1103-11. PubMed ID: 2240161 [TBL] [Abstract][Full Text] [Related]
9. Effects of plasma ochratoxin A and luminal pH on the jejunal absorption of ochratoxin A in rats. Kumagai S Food Chem Toxicol; 1988 Sep; 26(9):753-8. PubMed ID: 3209137 [TBL] [Abstract][Full Text] [Related]
10. Responses of broiler chickens orally challenged with Clostridium perfringens isolated from field cases of necrotic enteritis. Olkowski AA; Wojnarowicz C; Chirino-Trejo M; Drew MD Res Vet Sci; 2006 Aug; 81(1):99-108. PubMed ID: 16337982 [TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat. Torres S; Thim L; Milliat F; Vozenin-Brotons MC; Olsen UB; Ahnfelt-Rønne I; Bourhis J; Benderitter M; François A Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1563-71. PubMed ID: 18035212 [TBL] [Abstract][Full Text] [Related]
12. Distribution of 14C-ochratoxin A and 14C-ochratoxin B in rats: a comparison based on whole-body autoradiography. Breitholtz Emanuelsson A; Fuchs R; Hult K; Appelgren LE IARC Sci Publ; 1991; (115):201-3. PubMed ID: 1820334 [TBL] [Abstract][Full Text] [Related]
13. Absorption of iron in rats with experimental enteritis. Naveh Y; Shalata A; Shenker L; Coleman R Biometals; 2000 Mar; 13(1):29-35. PubMed ID: 10831222 [TBL] [Abstract][Full Text] [Related]
14. [Experimental study of the impact of a single use of indometacine on the morphological structure of the mucous coat of the stomach and small intestine]. Vymiatina ZK; Ivanova LA; Krylova SG Eksp Klin Gastroenterol; 2006; (3):32-6, 70. PubMed ID: 17203840 [TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. Tavakkolizadeh A; Shen R; Abraham P; Kormi N; Seifert P; Edelman ER; Jacobs DO; Zinner MJ; Ashley SW; Whang EE J Surg Res; 2000 Jun; 91(1):77-82. PubMed ID: 10816354 [TBL] [Abstract][Full Text] [Related]
16. Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine. Zanic-Grubisić T; Zrinski R; Cepelak I; Petrik J; Radić B; Pepeljnjak S Toxicol Appl Pharmacol; 2000 Sep; 167(2):132-9. PubMed ID: 10964764 [TBL] [Abstract][Full Text] [Related]
17. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783 [TBL] [Abstract][Full Text] [Related]
18. [State of the duodenal and jejunal endocrine system in chronic duodenitis and enteritis in childhood]. Paĭkov VL; Sokolova MI; Mikheeva EA Pediatriia; 1981 Dec; (12):18-21. PubMed ID: 7335416 [No Abstract] [Full Text] [Related]
19. [Morphological indicators of bacterial infection of the intestinal mucosa in rats with acute uremia]. Kozłowski W; Kulig A Patol Pol; 1982; 33(3-4):117-26. PubMed ID: 7162845 [No Abstract] [Full Text] [Related]
20. Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models. Lecci A; Carini F; Tramontana M; D'Aranno V; Marinoni E; Crea A; Bueno L; Fioramonti J; Criscuoli M; Giuliani S; Maggi CA J Pharmacol Exp Ther; 2001 Oct; 299(1):247-54. PubMed ID: 11561086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]